AI Summary
Thinking
Thinking
We reviewed 3 live results for l01cd04 cabazitaxel and narrowed them down to the 3 options that look most worth comparing first.
The options are Cabazitaxel, Cabazitaxel and Cabazitaxel.
Source: Selleck Chemicals
Description
Cabazitaxel (Cat. No. S3022) is a research-grade microtubule associated inhibitor and semi-synthetic derivative of a natural taxoid supplied by Selleck Chemicals. It suppresses cancer cell division and proliferation by inhibiting microtubule assembly and growth, and induces autophagy through the PI3K/Akt/mTOR pathway. Offered with up to 99.99% purity, a molecular weight of 835.93, CAS number 183133-96-2, and chemical formula C45H57NO14, it is validated for both in vitro assays and in vivo research applications.
Best for
oncology researchers, laboratory scientists, in vitro cancer cell growth assays and in vivo tumor xenograft studies
Rate this product
Source: EVER Pharma Spain
Description
Cabazitaxel de EVER Pharma Spain es un medicamento antineoplásico perteneciente a la clase de alcaloides de plantas y taxanos (código ATC L01CD04). Se presenta como concentrado para solución para perfusión con una dosis de 10 mg/ml (60 mg/6 ml por unidad). Está indicado en combinación con prednisona o prednisolona para el tratamiento de pacientes adultos con cáncer de próstata metastático resistente a la castración tratados previamente con docetaxel.
Best for
pacientes adultos con cáncer de próstata metastático resistente a la castración and tratamiento oncológico tras terapia previa con docetaxel en combinación con prednisona o prednisolona
Rate this product
Source: EVER Pharma Italy
Description
Cabazitaxel by EVER Pharma is an antineoplastic taxane medication supplied as a concentrate for solution for infusion. Formulated at a strength of 10 mg/ml, it is offered in unit strengths of 45 mg/4.5 ml, 50 mg/5 ml, and 60 mg/6 ml under ATC code L01CD04. It is indicated in combination with prednisone or prednisolone for treating adult patients with metastatic castration-resistant prostate cancer who have previously received a docetaxel-containing regimen.
Best for
Adult patients with metastatic castration resistant prostate cancer previously treated with a docetaxel-containing regimen and Treatment in combination with prednisone or prednisolone for metastatic castration resistant prostate cancer
Rate this product
| Compare | #1Cabazitaxel | #2Cabazitaxel | #3Cabazitaxel |
|---|---|---|---|
| Source | Selleck Chemicals | EVER Pharma Spain | EVER Pharma Italy |
| Description | Cabazitaxel (Cat. No. S3022) is a research-grade microtubule associated inhibitor and semi-synthetic derivative of a natural taxoid supplied by Selleck Chemicals. It suppresses cancer cell division and proliferation by inhibiting microtubule assembly and growth, and induces autophagy through the PI3K/Akt/mTOR pathway. Offered with up to 99.99% purity, a molecular weight of 835.93, CAS number 183133-96-2, and chemical formula C45H57NO14, it is validated for both in vitro assays and in vivo research applications. | Cabazitaxel de EVER Pharma Spain es un medicamento antineoplásico perteneciente a la clase de alcaloides de plantas y taxanos (código ATC L01CD04). Se presenta como concentrado para solución para perfusión con una dosis de 10 mg/ml (60 mg/6 ml por unidad). Está indicado en combinación con prednisona o prednisolona para el tratamiento de pacientes adultos con cáncer de próstata metastático resistente a la castración tratados previamente con docetaxel. | Cabazitaxel by EVER Pharma is an antineoplastic taxane medication supplied as a concentrate for solution for infusion. Formulated at a strength of 10 mg/ml, it is offered in unit strengths of 45 mg/4.5 ml, 50 mg/5 ml, and 60 mg/6 ml under ATC code L01CD04. It is indicated in combination with prednisone or prednisolone for treating adult patients with metastatic castration-resistant prostate cancer who have previously received a docetaxel-containing regimen. |
| Best for | oncology researchers, laboratory scientists, in vitro cancer cell growth assays and in vivo tumor xenograft studies | pacientes adultos con cáncer de próstata metastático resistente a la castración and tratamiento oncológico tras terapia previa con docetaxel en combinación con prednisona o prednisolona | Adult patients with metastatic castration resistant prostate cancer previously treated with a docetaxel-containing regimen and Treatment in combination with prednisone or prednisolone for metastatic castration resistant prostate cancer |
| Action | Selleck Chemicals | EVER Pharma Spain | EVER Pharma Italy |
| Rate this product |
"Cabazitaxel from Selleck Chemicals."
Note: TopFind AI compiles product and service information for general comparison purposes only.